Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

ISA 2022 | The role of lysosomes in amyloidogenesis by mesangial cells

Guillermo Herrera, MD, University of South Alabama College of Medicine, Mobile, AL, and Elba Turbat-Herrera, MD, University of South Alabama College of Medicine and the Mitchell Cancer Institute, Mobile, AL, discuss the role of lysosomes in amyloidogenesis by mesangial cells in the kidneys of patients with light chain (AL) amyloidosis, highlighting the possibility of developing drugs targeting this process to prevent renal damage. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.